Raj Denhoy
Stock Analyst at Jefferies
(1.90)
# 1,745
Out of 4,433 analysts
15
Total ratings
67.39%
Success rate
24.63%
Average return
Main Sectors:
10 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Maintains: Buy | $135 → $145 | $104.09 | +39.30% | 3 | Oct 21, 2021 | |
| EW Edwards Lifesciences | Maintains: Buy | n/a | $89.14 | - | 1 | Jul 30, 2021 | |
| HOLX Hologic | Maintains: Buy | n/a | $75.02 | - | 1 | Apr 5, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $8.29 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | n/a | $131.36 | - | 1 | Aug 2, 2018 | |
| AXGN AxoGen | Initiates: Buy | n/a | $6.04 | - | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | n/a | $217.64 | - | 2 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | n/a | $61.96 | - | 3 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | n/a | $79.67 | - | 1 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | n/a | $187.27 | - | 1 | Nov 3, 2017 |
Abbott Laboratories
Oct 21, 2021
Maintains: Buy
Price Target: $135 → $145
Current: $104.09
Upside: +39.30%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: n/a
Current: $89.14
Upside: -
Hologic
Apr 5, 2021
Maintains: Buy
Price Target: n/a
Current: $75.02
Upside: -
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $8.29
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: n/a
Current: $131.36
Upside: -
AxoGen
Nov 30, 2017
Initiates: Buy
Price Target: n/a
Current: $6.04
Upside: -
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: n/a
Current: $217.64
Upside: -
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: n/a
Current: $61.96
Upside: -
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: n/a
Current: $79.67
Upside: -
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: n/a
Current: $187.27
Upside: -